Active
SME

Zenith Drugs Ltd

Zenith Drugs Ltd IPO opened on 19 Feb 2024 and closed on 22 Feb 2024, with a price band of ₹79–₹79 per share. The IPO had a lot size of 1600 shares, requiring a minimum investment of ₹1,26,400 per lot at the upper price band. The issue size was ₹40.68 crore, and the shares get listed on 27 Feb 2024.

Zenith Drugs Ltd IPO Details

Listing Date

27 Feb 2024

Bid Price

₹79 - ₹79

Lot Size

1600 Shares

Minimum Investment

₹1,26,400 / 2 Lots

Issue Size

₹40.68 Cr

Key Dates to Track

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

19th Feb

tick

Offer End Date

22nd Feb

tick

Allotment Date

23rd Feb

tick

Refund Initiation

26th Feb

tick

Demat Transfer

26th Feb

tick

Listing Date

27th Feb

Zenith Drugs Ltd Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 91.58% 64.09%
Public Group 8.42% 35.91%

Zenith Drugs Ltd IPO Reservation

QIB Shares Offered 21,47,200 (41.7%)
NII (HNI) Shares Offered 6,44,800 (12.52%)
Retail Shares Offered 15,04,000 (29.21%)
Anchor Investor Shares Offered 0 (0%)
Total Shares Offered 51,48,800
Total Shares With Anchor Investor 51,48,800

Zenith Drugs Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1,600 ₹1,26,400
Retail (Max) 1 1,600 ₹1,26,400
S HNI (Min) 2 3,200 ₹2,52,800
S HNI (Max) 7 11,200 ₹8,84,800
B HNI (MIN) 8 12,800 ₹10,11,200

Zenith Drugs Ltd IPO registrar

Bigshare Services Pvt Ltd
Phone Number +91 - 22 - 6263 8200;
Email Id ipo@bigshareonline.com
Website www.bigshareonline.com

Zenith Drugs Ltd IPO Lead Manager

1. Gretex Corporate Services Ltd

Zenith Drugs Ltd Financial Information

March 31, 2024 March 31, 2023 March 31, 2022
Net Worth ₹62.26 Cr ₹17.72 Cr ₹12.09 Cr
Reserves and Surplus ₹45.12 Cr ₹17.32 Cr ₹11.69 Cr
Total Borrowing ₹24.64 Cr ₹26.11 Cr ₹18.81 Cr

Zenith Drugs Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid Subscription (Times)
Qualified Institutional Buyers (QIBs) 0 0 0
Non Institutional Investors (NIIs) 0 59,61,600 0
Retail Individual Investors (RIIs) 0 2,85,58,400 0
Total 0 3,75,60,000 7.2949

Strength of Zenith Drugs Ltd

  • Experienced Promoters and Management Team.
  • Cost Efficiency.
  • Formulation & Development.
  • Regulatory Compliance.
  • Global Reach.
  • Product Portfolio.
  • Supply Chain Efficiency.
  • Scalable Business Model.
  • Strong sales, marketing, and distribution capabilities.

Risks Involved

  • There are outstanding legal proceedings involving the Company, Promoters and Directors. Any adverse decision in such proceeding may have a material adverse effect on its business, results of operations and financial condition.
  • Any manufacturing or quality control problems may disrupt its business operations, damage the company reputation for high quality production and expose it to potential litigation or other liabilities, which would negatively impact its business, prospects, cash flows, results of operations and financial condition.
  • The company highly depends on its major raw materials and a few key suppliers who help it procure the same. the Company has not entered into long-term agreements with its suppliers for supply of raw materials. In the event the company is unable to procure adequate amounts of raw materials, at competitive prices its business, results of operations and financial condition may be adversely affected.
  • The company conducts its business activities on a purchase order basis and therefore, has not entered into long-term agreements with its customers except government contracts.
  • Its business activities are exposed to fluctuations in the prices of raw materials.
  • If the company cannot respond adequately to the increased competition its expect to face, the company will lose market share and its profits will decline, which will adversely affect its business, results of operations and financial condition.
  • The company is required to obtain, renew or maintain certain statutory and regulatory permits and approvals required to operate its business and if the company fail to do so in a timely manner or at all and its business, financial conditions, results of operations, and cash flows may be adversely affected.
  • The Company is reliant on the demand from the pharmaceutical industry for a significant portion of its revenue. Any downturn in the pharmaceutical industry or an inability to increase or effectively manage its sales could have an adverse impact on the Company's business and results of operations.
  • Continued operations of its manufacturing facility are critical to the company business and any disruption in the operation of its manufacturing facility may have a material adverse effect on its business, results of operations and financial condition.
  • Majority of its revenue is dependent on two products i.e., ORS Powder and Liquid Orals, if the company is unable to anticipate or adapt to evolving upgradation of products or inability to ensure product quality or reduction in the demand of such products may adversely impact its revenue from operations and growth prospects.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Safety Controls AND Devices Limited IPO
Bidding Period
6th Apr 2026 - 4th Apr 2026
Price Range
₹75.0 - 80.0
IPO Size
₹48,00,00,000
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Engineering Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Industries Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
SAI PARENTERAL'S LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹372.0 - 392.0
IPO Size
₹4,09,00,00,000
AMIR CHAND JAGDISH KUMAR EXPORTS LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹201.0 - 212.0
IPO Size
₹4,40,00,00,000
HIGHNESS MICROELECTRONICS LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹114.0 - 120.0
IPO Size
₹22,00,00,000
POWERICA LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹375.0 - 395.0
IPO Size
₹11,00,00,00,000
TIPCO ENGINEERING INDIA LIMITED IPO
Bidding Period
23rd Mar 2026 - 3rd Mar 2026
Price Range
₹84.0 - 89.0
IPO Size
₹61,00,00,000
SPECIALITY MEDICINES LIMITED IPO
Bidding Period
20th Mar 2026 - 3rd Mar 2026
Price Range
₹117.0 - 124.0
IPO Size
₹29,00,00,000
CENTRAL MINE PLANNING AND DESIGN INSTITUTE LIMITED IPO
Bidding Period
20th Mar 2026 - 3rd Mar 2026
Price Range
₹163.0 - 172.0
IPO Size
₹18,42,00,00,000
NOVUS LOYALTY LIMITED IPO
Bidding Period
17th Mar 2026 - 3rd Mar 2026
Price Range
₹139.0 - 146.0
IPO Size
₹60,00,00,000
GSP CROP SCIENCE LIMITED IPO
Bidding Period
16th Mar 2026 - 3rd Mar 2026
Price Range
₹304.0 - 320.0
IPO Size
₹4,00,00,00,000
INNOVISION LIMITED IPO
Bidding Period
10th Mar 2026 - 3rd Mar 2026
Price Range
₹494.0 - 519.0
IPO Size
₹3,06,00,00,000
RAAJMARG INFRA INVESTMENT TRUST IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹99.0 - 100.0
IPO Size
₹60,00,00,00,000
APSIS AEROCOM LIMITED IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹104.0 - 110.0
IPO Size
₹36,00,00,000
RAJPUTANA STAINLESS LIMITED IPO
Bidding Period
9th Mar 2026 - 3rd Mar 2026
Price Range
₹116.0 - 122.0
IPO Size
₹2,55,00,00,000
SRINIBAS PRADHAN CONSTRUCTIONS LIMITED IPO
Bidding Period
6th Mar 2026 - 3rd Mar 2026
Price Range
₹91.0 - 98.0
IPO Size
₹20,00,00,000
ELFIN AGRO INDIA LIMITED IPO
Bidding Period
5th Mar 2026 - 3rd Mar 2026
Price Range
₹47.0 - 47.0
IPO Size
₹25,00,00,000
SEDEMAC MECHATRONICS LIMITED IPO
Bidding Period
4th Mar 2026 - 3rd Mar 2026
Price Range
₹1287.0 - 1352.0
IPO Size
₹10,87,00,00,000
ACETECH ECOMMERCE LIMITED IPO
Bidding Period
27th Feb 2026 - 3rd Mar 2026
Price Range
₹106.0 - 112.0
IPO Size
₹49,00,00,000
STRIDERS IMPEX LIMITED IPO
Bidding Period
26th Feb 2026 - 3rd Mar 2026
Price Range
₹71.0 - 72.0
IPO Size
₹36,00,00,000
OMNITECH ENGINEERING LIMITED IPO
Bidding Period
25th Feb 2026 - 2nd Feb 2026
Price Range
₹216.0 - 227.0
IPO Size
₹5,83,00,00,000
YAAP DIGITAL LIMITED IPO
Bidding Period
25th Feb 2026 - 2nd Feb 2026
Price Range
₹138.0 - 145.0
IPO Size
₹80,11,00,000
  • All
  • MainBoard
  • SME
GSP CROP SCIENCE LIMITED IPO
Issue Prize
320.00
Listing Day Close
356.10(11.25%)
INNOVISION LIMITED IPO
Issue Prize
519.00
Listing Day Close
372.80(-28.13%)
RAAJMARG INFRA INVESTMENT TRUST IPO
Issue Prize
100.00
Listing Day Close
106.83(7.00%)
APSIS AEROCOM LIMITED IPO
Issue Prize
110.00
Listing Day Close
160.65(46.36%)
RAJPUTANA STAINLESS LIMITED IPO
Issue Prize
122.00
Listing Day Close
112.90(-7.38%)
SRINIBAS PRADHAN CONSTRUCTIONS LIMITED IPO
Issue Prize
98.00
Listing Day Close
104.40(6.12%)
ELFIN AGRO INDIA LIMITED IPO
Issue Prize
47.00
Listing Day Close
47.60(2.13%)
SEDEMAC MECHATRONICS LIMITED IPO
Issue Prize
1352.00
Listing Day Close
1452.10(7.40%)
ACETECH ECOMMERCE LIMITED IPO
Issue Prize
112.00
Listing Day Close
117.60(5.36%)
STRIDERS IMPEX LIMITED IPO
Issue Prize
72.00
Listing Day Close
66.50(-6.94%)
OMNITECH ENGINEERING LIMITED IPO
Issue Prize
227.00
Listing Day Close
205.15(-9.69%)
YAAP DIGITAL LIMITED IPO
Issue Prize
145.00
Listing Day Close
133.35(-8.28%)
PNGS REVA DIAMOND JEWELLERY LIMITED IPO
Issue Prize
386.00
Listing Day Close
413.95(7.25%)
CLEAN MAX ENVIRO ENERGY SOLUTIONS LIMITED IPO
Issue Prize
1053.00
Listing Day Close
867.90(-17.57%)
SHREE RAM TWISTEX LIMITED IPO
Issue Prize
104.00
Listing Day Close
73.45(-29.81%)
MOBILISE APP LAB LIMITED IPO
Issue Prize
80.00
Listing Day Close
67.30(-16.25%)
KIAASA RETAIL LIMITED IPO
Issue Prize
127.00
Listing Day Close
116.85(-7.87%)
ACCORD TRANSFORMER AND SWITCHGEAR LIMITED IPO
Issue Prize
46.00
Listing Day Close
52.50(15.22%)
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Issue Prize
79.00
Listing Day Close
80.48(1.27%)
MANILAM INDUSTRIES INDIA LIMITED IPO
Issue Prize
69.00
Listing Day Close
52.45(-24.64%)

Frequently Asked Questions

What is Zenith Drugs Ltd IPO?

Answer Field

Zenith Drugs Ltd IPO is a SME IPO of 51,48,800 equity shares of a face value of ₹10 aggregating up to ₹40.68 Crores. The issue is priced at ₹79 to ₹79 per share. The minimum order quantity is 1600 Shares. The IPO opens on February 19, 2024, and closes on February 22, 2024. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

When Zenith Drugs Ltd IPO will open?

Answer Field

The Zenith Drugs Ltd IPO opens on February 19, 2024 and closes on February 22, 2024.

What is the lot size of Zenith Drugs Ltd?

Answer Field

Zenith Drugs Ltd lot size is 1600 shares, and the minimum amount required is ₹1,26,400.

How to apply for Zenith Drugs Ltd IPO?

Answer Field

You can apply in Zenith Drugs Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Zenith Drugs Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Zenith Drugs Ltd IPO will be done on February 23, 2024, and the allotted shares will be credited to your demat account by February 26, 2024.

When is Zenith Drugs Ltd IPO listing date?

Answer Field

The Zenith Drugs Ltd listing date is February 27, 2024.

Who is the registrar of Zenith Drugs Ltd IPO?

Answer Field

The registrar of Zenith Drugs Ltd IPO is Bigshare Services Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Gretex Corporate Services Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Zenith Drugs Ltd IPO?

Answer Field

The fresh issue size is ₹40.68 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Zenith Drugs Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 1600 shares and ₹1,26,400 amount.

How can I approve the UPI mandate request for Zenith Drugs Ltd IPO?

Answer Field

To apply for Zenith Drugs Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Zenith Drugs Ltd?

Answer Field

The price of each Zenith Drugs Ltd share will be ranging in between ₹79 to ₹79 per share.

What is the cut-off time for the UPI mandate for Zenith Drugs Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, February 22, 2024.

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|